Companies/Securities in Focus
|20 May 2022 18:12:44||DOD||Notification the exercise of DOD-W2||Detail|
News Archive (5 years)
|20 May 2022 18:12||DOD||Notification the exercise of DOD-W2||Detail|
|12 May 2022 20:27||DOD||Financial Performance Quarter 1 (F45) (Reviewed) (Edited)||Detail|
|12 May 2022 19:24||DOD||Management Discussion and Analysis Quarter 1 Ending 31 Mar 2022||Detail|
|12 May 2022 19:24||DOD||Financial Performance Quarter 1 (F45) (Reviewed)||Detail|
|12 May 2022 19:24||DOD||Financial Statement Quarter 1/2022 (Reviewed)||ZIP|
|21 Apr 2022 22:08||DOD||Shareholders meeting's resolution||Detail|
|24 Feb 2022 22:12||DOD||Notification of Convening the 2022 Annual General Meeting and Dividend Omission Payment||Detail|
|24 Feb 2022 21:47||DOD||Management Discussion and Analysis Yearly Ending 31 Dec 2021||Detail|
|24 Feb 2022 21:46||DOD||Financial Performance Yearly (F45) (Audited)||Detail|
|24 Feb 2022 21:45||DOD||Financial Statement Yearly 2021 (Audited)||ZIP|
|28 Jan 2022 21:56||DOD||Use of proceeds from initial public offering of ordinary shares||Detail|
|03 Dec 2021 08:44||DOD||Information Memorandum of Warrants to Purchase Newly Issued Ordinary Shares of DOD Biotech Public Company Limited No. 2 (DOD-W2)||Detail|
|03 Dec 2021 06:30||mai||mai adds new listed securities : DOD-W2 to be traded on December 7, 2021||Detail|
|01 Dec 2021 07:06||DOD||Report on the results of the sale of warrants offered to existing common shareholders (F53-5)||Detail|
|11 Nov 2021 17:46||DOD||Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021||Detail|
|11 Nov 2021 17:46||DOD||Financial Performance Quarter 3 (F45) (Reviewed)||Detail|
|11 Nov 2021 17:45||DOD||Financial Statement Quarter 3/2021 (Reviewed)||ZIP|
|04 Nov 2021 17:39||DOD||The allocation of warrants to the existing shareholders of foreign companies||Detail|
|02 Nov 2021 18:52||DOD||Published Minute of the1/2021 Extraordinary Shareholders Meeting on the Company's website||Detail|
|26 Oct 2021 13:10||DOD||Determined offering date the issuance of warrants of DOD Biotech Public Company Limited No. 2 (DOD-W2)||Detail|
Investor Alert News is the sign meaning that there is an important information that shareholders and public investors should concern before making any voting or investing decisions.
Reprimand News is the sign meaning that the SET has publicly reprimanded the listed company for its breach of, or non-compliance with, the SET's rules and regulations.
Contract Adjustment (CA) is the TFEX news that announced the arrangements for the contract adjustment in accordance with the corporate action of the underlying stock.
PL is the TFEX news that announced the maximum number of futures or options contracts an investor is allowed to hold (Position Limit).